Nexus BioQuest is a pre-clinical contract research organisation that collaborates with Biotechnology and Pharmaceutical companies in order to help accelerate their pre-clinical immunology research programmes.

At our core we have:
• Expertise- Deep immunology experience and knowledge in order to solve complex research problems.
• Tempo- Agile and quickly expandable capability focused on reducing bureaucracy and burden so that collaborative science can thrive.
• Collaboration- Be open and mutually trusting to maximise the impact of research and step away from a transactional approach.

Our science will provide a comprehensive suite of solutions which will model the immune response depending on the research question being asked. These will form a pre-clinical package of assays including:

• Relevant target expression.
• Mode of action.
• Efficacy.
• Biomarkers.
• Predictive immuno-toxicity.

This will allow us to support our partners at multiple steps within the preclinical drug development process. All of our work is built on our deep understanding of the immune response, allowing us to provide relevant, customisable, cutting-edge assays, to advance our partners’ drug development programs.